Juan Antonio Sanchez-Arias

Juan Antonio Sanchez-Arias

Auto-generated profile, based on publicly available information

Juan Antonio Sanchez-Arias

Small Molecule Discovery Platform, Molecular Therapeutics Program, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2016 in Neuropsychopharmacology
Verified
Journal Article
Closed access
MCMar Cuadrado-Tejedor
Mar Cuadrado-Tejedor
CGCarolina Garcia-Barroso
Carolina Garcia-Barroso
JSJuan A Sánchez-Arias
Juan A Sánchez-Arias
ORObdulia Rabal
Obdulia Rabal
MPMarta Pérez-González
Marta Pérez-González
AGAna Garcia-Osta
Ana Garcia-Osta


15 May 2015 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
MAMaria S Aymerich
Maria S Aymerich
EREstefania Rojo-Bustamante
Estefania Rojo-Bustamante
CMCarmen Molina
Carmen Molina
MCMarta Celorrio
Marta Celorrio
JSJuan A. Sánchez-Arias
Juan A. Sánchez-Arias
Rafael FrancoRafael Franco
Rafael Franco

27 December 2016 in ACS Chemical Neuroscience
Verified
Journal Article
Closed access
JSJuan A. Sánchez-Arias
Juan A. Sánchez-Arias
ORObdulia Rabal
Obdulia Rabal
MCMar Cuadrado-Tejedor
Mar Cuadrado-Tejedor
IMIrene de Miguel
Irene de Miguel
MPMarta Pérez-González
Marta Pérez-González
JOJulen Oyarzabal
Julen Oyarzabal

1 March 1991 in Biochemical Journal
Verified
Journal Article
Closed access
JAJ F Alvarez
J F Alvarez
JSJ A Sánchez-Arias
J A Sánchez-Arias
AGA Guadaño
A Guadaño
FEFrancisco Estévez
Francisco Estévez
IVI Varela
I Varela
JMJose M Mato
Jose M Mato
The addition to intact cells of an inositol phospho-oligosaccharide (POS), which is the polar head-group of an insulin-sensitive glycosylphosphatidylinositol, mimics and may mediate some of the biological effects of this hormone. Here we report the existence of a POS transport system in hepatocytes. This POS transport system is specific and time- and dose-dependent. Insulin-resistance caused by dexamethasone administration to rats was accompanied by a decrease in the hepatocyte POS transport system. In contrast, bilateral adrenalectomy provoked a significant increase in the transport of POS. Both the temporal uptake of POS and the regulation of this process by conditions known to modify the sensitivity to insulin suggest that this novel transport system might be involved in the insulin signalling mechanism.

1 September 2016 in The Journal of Pharmacology and Experimental Therapeutics
Verified
Journal Article
Open access
PDF file
EPEva Martínez Pinilla
Eva Martínez Pinilla
ORObdulia Rabal
Obdulia Rabal
IRIrene Reyes-Resina
Irene Reyes-Resina
MZMarta Zamarbide
Marta Zamarbide
GNGemma Navarro
Gemma Navarro
Rafael FrancoRafael Franco
Rafael Franco
Cannabinoid receptors are G-protein-coupled receptors with potential in a variety of diseases. There are two different cannabinoid receptors types; ligands for type 2 (CB2R) show more promise than those for type 1 (CB1R) as they lack psychotropic actions. However, the lipophilic nature of CB2R ligands and the complex pharmacology of these receptors are delaying the translational success of medications targeting the endocannabinoid system. We here report the discovery and synthesis of a fluorophore-labeled high-affinity and CB2R-selective ligand that may be used in nonradioactive binding assays. The novel fluorophore-conjugated compound was useful for pharmacological characterization of CB2R by using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. This methodology does not require radiolabelled compounds and may be undertaken in homogeneous conditions and in living cells. TR-FRET assays disclosed a previously unreported second affinity site and showed conformational changes in CB2R forming receptor heteromers with another G-protein-coupled receptor.